- |||||||||| camptothecin/fleximer conjugate (XMT-1001) / Mersana
Trial completion, Enrollment change, Trial primary completion date, Metastases: A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Sep 21, 2016
P1, N=30, Completed,
Active, not recruiting --> Completed | N=24 --> 30 | Trial primary completion date: Jun 2013 --> Dec 2011
- |||||||||| camptothecin/fleximer conjugate (XMT-1001) / Mersana
Enrollment closed, Metastases: A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Feb 29, 2012
P1, N=24, Active, not recruiting,
Active, not recruiting --> Completed | N=24 --> 30 | Trial primary completion date: Jun 2013 --> Dec 2011 Recruiting --> Active, not recruiting
|
